These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 11351295

  • 1. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance.
    Harbottle A, Daly AK, Atherton K, Campbell FC.
    Int J Cancer; 2001 Jun 15; 92(6):777-83. PubMed ID: 11351295
    [Abstract] [Full Text] [Related]

  • 2. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ, Kakehi Y, Yoshida O.
    Int J Urol; 1997 Nov 15; 4(6):583-90. PubMed ID: 9477189
    [Abstract] [Full Text] [Related]

  • 3. Detoxification of 1-chloro-2,4-dinitrobenzene in MCF7 breast cancer cells expressing glutathione S-transferase P1-1 and/or multidrug resistance protein 1.
    Diah SK, Smitherman PK, Townsend AJ, Morrow CS.
    Toxicol Appl Pharmacol; 1999 Jun 01; 157(2):85-93. PubMed ID: 10366541
    [Abstract] [Full Text] [Related]

  • 4. Glutathione-dependent biotransformation of the alkylating drug thiotepa and transport of its metabolite monoglutathionylthiotepa in human MCF-7 breast cancer cells.
    Cnubben NH, Rommens AJ, Oudshoorn MJ, Van Bladeren PJ.
    Cancer Res; 1998 Oct 15; 58(20):4616-23. PubMed ID: 9788613
    [Abstract] [Full Text] [Related]

  • 5. Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.
    Zaja R, Caminada D, Loncar J, Fent K, Smital T.
    Toxicol Appl Pharmacol; 2008 Mar 01; 227(2):207-18. PubMed ID: 18076962
    [Abstract] [Full Text] [Related]

  • 6. Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.
    Hatanaka H, Abe Y, Naruke M, Asai S, Miyachi H, Kawakami T, Nagata J, Kamochi J, Kijima H, Yamazaki H, Scanlon KJ, Ueyama Y, Nakamura M.
    Anticancer Res; 2001 Mar 01; 21(2A):879-85. PubMed ID: 11396179
    [Abstract] [Full Text] [Related]

  • 7. Enhanced cytotoxicity and nuclear accumulation of doxorubicin-loaded nanospheres in human breast cancer MCF7 cells expressing MRP1.
    Aouali N, Morjani H, Trussardi A, Soma E, Giroux B, Manfait M.
    Int J Oncol; 2003 Oct 01; 23(4):1195-201. PubMed ID: 12964004
    [Abstract] [Full Text] [Related]

  • 8. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
    Hour TC, Chen J, Huang CY, Guan JY, Lu SH, Hsieh CY, Pu YS.
    Anticancer Res; 2000 Oct 01; 20(5A):3221-5. PubMed ID: 11062746
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100.
    Kim HS, Lee TB, Choi CH.
    Biochem Biophys Res Commun; 2001 Feb 16; 281(1):109-14. PubMed ID: 11178967
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L, Rieger J, Winter S, Streffer J, Esser P, Dichgans J, Meyermann R, Weller M.
    Acta Neuropathol; 2000 May 16; 99(5):555-62. PubMed ID: 10805101
    [Abstract] [Full Text] [Related]

  • 11. Glutathione S-transferases in wild-type and doxorubicin-resistant MCF-7 human breast cancer cell lines.
    Wang K, Ramji S, Bhathena A, Lee C, Riddick DS.
    Xenobiotica; 1999 Feb 16; 29(2):155-70. PubMed ID: 10199592
    [Abstract] [Full Text] [Related]

  • 12. Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979.
    Shepard RL, Cao J, Starling JJ, Dantzig AH.
    Int J Cancer; 2003 Jan 01; 103(1):121-5. PubMed ID: 12455064
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation.
    Wang H, Li X, Chen T, Wang W, Liu Q, Li H, Yi J, Wang J.
    Oncol Rep; 2013 Feb 01; 29(2):676-84. PubMed ID: 23229154
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic.
    Liu J, Chen H, Miller DS, Saavedra JE, Keefer LK, Johnson DR, Klaassen CD, Waalkes MP.
    Mol Pharmacol; 2001 Aug 01; 60(2):302-9. PubMed ID: 11455017
    [Abstract] [Full Text] [Related]

  • 15. Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
    Nielsen D, Maare C, Eriksen J, Litman T, Skovsgaard T.
    Int J Radiat Oncol Biol Phys; 2001 Nov 15; 51(4):1050-7. PubMed ID: 11704330
    [Abstract] [Full Text] [Related]

  • 16. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines.
    Utz I, Gekeler V, Ise W, Beck J, Spitaler M, Grunicke H, Hofmann J.
    Anticancer Res; 1996 Nov 15; 16(1):289-96. PubMed ID: 8615623
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
    Liu B, Staren ED, Iwamura T, Appert HE, Howard JM.
    J Surg Res; 2001 Aug 15; 99(2):179-86. PubMed ID: 11469885
    [Abstract] [Full Text] [Related]

  • 18. Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 Isomers, tetrataisohydroquinolin derivatives.
    Yan F, Jiang Y, Li YM, Zhen X, Cen J, Fang WR.
    Biol Pharm Bull; 2008 Jun 15; 31(6):1258-64. PubMed ID: 18520065
    [Abstract] [Full Text] [Related]

  • 19. Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid.
    Kim HS, Min YD, Choi CH.
    Biochem Biophys Res Commun; 2001 Apr 27; 283(1):64-71. PubMed ID: 11322768
    [Abstract] [Full Text] [Related]

  • 20. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.
    Wortelboer HM, Usta M, van der Velde AE, Boersma MG, Spenkelink B, van Zanden JJ, Rietjens IM, van Bladeren PJ, Cnubben NH.
    Chem Res Toxicol; 2003 Dec 27; 16(12):1642-51. PubMed ID: 14680379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.